Background: Myeloid Sarcoma (MS) is a rare hematologic cancer, which can occur as a breast mass to be distinguished from other non-hematopoietic tumors. Case Presentation: This report describe the unusual clinical history of a young woman diagnosed with MS. Radiotherapy/surgery alone may be inadequate, while chemotherapy and hematopoietic stem cell transplantation demonstrated to improve the prognosis for the isolated extramedullary localization. Conclusion: Performing a needle biopsy in order to exclude the diagnosis of a primitive breast disease is irreplaceable.
Breast Location for De Novo Extramedullary Myeloid Sarcoma / Tazzioli, Giovanni; Enza, Palma; Gambini, Anna; Messerotti, Andrea; Potenza, Leonardo; Luppi, Mario; Antonella, Drago; Maria Grazia Amorico, ; Barbolini, Monica; Guido, Ficarra; Piacentini, Federico. - In: CLINICS IN ONCOLOGY. - ISSN 2474-1663. - 3:(2018), pp. 1-1.
Breast Location for De Novo Extramedullary Myeloid Sarcoma
Giovanni Tazzioli;GAMBINI, ANNA;Andrea Messerotti;Leonardo Potenza;Mario Luppi;Monica Barbolini;Federico Piacentini
2018
Abstract
Background: Myeloid Sarcoma (MS) is a rare hematologic cancer, which can occur as a breast mass to be distinguished from other non-hematopoietic tumors. Case Presentation: This report describe the unusual clinical history of a young woman diagnosed with MS. Radiotherapy/surgery alone may be inadequate, while chemotherapy and hematopoietic stem cell transplantation demonstrated to improve the prognosis for the isolated extramedullary localization. Conclusion: Performing a needle biopsy in order to exclude the diagnosis of a primitive breast disease is irreplaceable.File | Dimensione | Formato | |
---|---|---|---|
DE NOVO BREAST SARCOMA.pdf
accesso aperto
Descrizione: Articolo principale
Tipologia:
Versione dell'editore (versione pubblicata)
Dimensione
6.08 MB
Formato
Adobe PDF
|
6.08 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris